Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases
Abstract Breast cancer brain metastases (BCBM) are a common and devastating complication of metastatic breast cancer with conventional systemic therapies demonstrating limited effectiveness. Consequently, radiotherapy (RT) ± surgery remains the cornerstone of BCBM management. Because preclinical and...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2022-04-01
|
| Серія: | npj Breast Cancer |
| Онлайн доступ: | https://doi.org/10.1038/s41523-022-00404-2 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|